ALDX
Aldeyra Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.66
−3.58%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-60.8%
Return on equity
-48.5%
Return on assets
-63.3%
Return on invested capital
0.00x
Asset turnover
-$22.0M
Cash from operations
$0.75
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026